These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical Significance of Microvascular Inflammation in the Absence of Anti-HLA DSA in Kidney Transplantation. Parajuli S, Redfield RR, Garg N, Aziz F, Mohamed M, Astor BC, Zhong W, Djamali A, Mandelbrot DA. Transplantation; 2019 Jul; 103(7):1468-1476. PubMed ID: 30335696 [Abstract] [Full Text] [Related]
5. The immunohistochemical expression of von Willebrand factor, T-cadherin, and Caveolin-1 is increased in kidney allograft biopsies with antibody-mediated injury. Teixeira AC, Távora F, de Deus E Silva MLF, Prado RMG, de Matos Esmeraldo R, de Sandes-Freitas TV. Clin Exp Nephrol; 2021 Mar; 25(3):305-314. PubMed ID: 33242156 [Abstract] [Full Text] [Related]
6. The clinical and molecular significance of C4d staining patterns in renal allografts. Hayde N, Bao Y, Pullman J, Ye B, Calder BR, Chung M, Schwartz D, Alansari A, de Boccardo G, Ling M, Akalin E. Transplantation; 2013 Feb 27; 95(4):580-8. PubMed ID: 23274969 [Abstract] [Full Text] [Related]
7. The relationship of microvascular inflammation with antibody-mediated rejection in kidney transplantation. Nankivell BJ, Taverniti A, Viswanathan S, Ronquillo J, Carroll R, Sharma A. Am J Transplant; 2024 Jul 30. PubMed ID: 39084463 [Abstract] [Full Text] [Related]
9. Detection of Complement-binding Donor-specific Antibodies, Not IgG-antibody Strength Nor C4d Status, at Antibody-mediated Rejection Diagnosis Is an Independent Predictor of Kidney Graft Failure. Malheiro J, Santos S, Tafulo S, Dias L, Martins S, Fonseca I, Almeida M, Pedroso S, Beirão I, Castro-Henriques A, Cabrita A. Transplantation; 2018 Nov 30; 102(11):1943-1954. PubMed ID: 29757900 [Abstract] [Full Text] [Related]
10. Pathology of C4d-negative antibody-mediated rejection in renal allografts. Haas M. Curr Opin Organ Transplant; 2013 Jun 30; 18(3):319-26. PubMed ID: 23283250 [Abstract] [Full Text] [Related]
11. Molecular signatures and clinical outcomes of transplant glomerulopathy stratified by microvascular inflammation and donor-specific antibody. Lubetzky M, Hayde N, Ó Broin P, Ajaimy M, Bao Y, Mohammed O, Schwartz D, Pullman J, Akalin E. Clin Transplant; 2019 Mar 30; 33(3):e13469. PubMed ID: 30578675 [Abstract] [Full Text] [Related]
19. Molecular diagnosis of antibody-mediated rejection: Evaluating biopsy-based transcript diagnostics in the presence of donor-specific antibodies but without microvascular inflammation, a single-center descriptive analysis. Harmacek D, Weidmann L, Castrezana Lopez K, Schmid N, Korach R, Bortel N, von Moos S, Rho E, Helmchen B, Gaspert A, Schachtner T. Am J Transplant; 2024 Sep 30; 24(9):1652-1663. PubMed ID: 38548057 [Abstract] [Full Text] [Related]
20. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis. Gosset C, Viglietti D, Rabant M, Vérine J, Aubert O, Glotz D, Legendre C, Taupin JL, Duong Van-Huyen JP, Loupy A, Lefaucheur C. Kidney Int; 2017 Sep 30; 92(3):729-742. PubMed ID: 28554738 [Abstract] [Full Text] [Related] Page: [Next] [New Search]